2
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Keratosis, Actinic
22
Cholangiocarcinoma
8
Carcinoma, Basal Cell
8
Carcinoma, Non-Small-Cell Lung
7
Squamous Cell Carcinoma of Head and Neck
6
Skin Neoplasms
4
Bile Duct Neoplasms
4
Pancreatic Neoplasms
3
Mesothelioma, Malignant
3
Lung Neoplasms
3
Liver Neoplasms
3
Leukoplakia, Oral
3
Colorectal Neoplasms
3
Warts
2
Tongue Neoplasms
2
Prostatic Neoplasms
2
Pleural Diseases
2
Neoplasms
2
Neoplasm Metastasis
2
Mycosis Fungoides
2
Glioblastoma
2
Esophageal Neoplasms
2
Carcinoma, Squamous Cell
2
Bowen's Disease
2
Basal Cell Nevus Syndrome
2
Barrett Esophagus
2
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Interventions
Cisplatin
30
Magnetic Resonance Spectroscopy
21
Radiotherapy
20
pembrolizumab
18
Specimen Handling
17
Cetuximab
16
Biopsy
13
Radiotherapy, Intensity-Modulated
12
Radiation
11
Paclitaxel
11
Carboplatin
11
Surveys and Questionnaires
10
Fluorouracil
10
Drug Therapy
10
1,2-diaminocyclohexaneplatinum II citrate
10
Platinum
9
Surgical Procedures, Operative
8
X-Rays
7
Taxes
7
Celecoxib
7
Standard of Care
6
Sentinel Lymph Node Biopsy
6
Observation
5
Nivolumab
5
cemiplimab
4
Metformin
4
Interviews as Topic
4
Immunohistochemistry
4
Fluorodeoxyglucose F18
4
Docetaxel
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Mouth Neoplasms
×
Photochemotherapy
×
Clear all
NCT03638622
2021-02-21
UH3-India
Massachusetts General Hospital
Phase 1/2
Completed
30 enrolled
4 charts